In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants

Journal of Liposome Research

Volumn 20, Issue 1, 2010, Pages 1-8

  Madrigal Carballo, Sergio ^a   Vila, Amparo O ^b   Sibaja, Maria ^a   Reed, Jess D ^c   Molina, Francisco ^b  

^a National University   (Costa Rica)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chitosan; Hen egg white lysozyme; Immunoadjuvants; Liposomes

Indexed keywords

BIOPOLYMER; CHITOSAN; EGG WHITE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; LIPOSOME; LYSOZYME; PHOSPHATE BUFFERED SALINE; CATION; HEN EGG LYSOZYME; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; COCULTURE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRICITY; FEMALE; FLUORESCENCE MICROSCOPY; HYBRIDOMA CELL CULTURE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ZETA POTENTIAL; ANIMAL; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOPOLYMERS; CATIONS; CHITOSAN; DRUG DELIVERY SYSTEMS; FEMALE; INTERLEUKIN-2; LIPOSOMES; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MURAMIDASE; PEYER'S PATCHES; POLYMERS;

EID: 77149162709     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100903015009     Document Type: Article

References (56)

1. Agerkvist I, Eriksson L, Enfors S. (1990). Selective flocculation with chitosan in Escherichia coli disintegrates: effects of pH and nuclease treatment. Enz Microb Technol 12:584-590.
2. Alvarez MA, Seyler D, Madrigal-Carballo S, Vila AO, Molina F. (2007). Influence of the electrical interface properties on the rheological behavior of sonicated soy lecithin dispersions. J Coll Interf Sci 309:279-282.
3. Alving CR, Banerji B, Shiba T, Kotani S, Clements JD, Richards RL. (1980). Liposomes as vehicles for vaccines. Prog Clin Biol Res 47:339-355.
4. Arai K, Kinumaki T, Fujita T. (1968). Toxicity of chitosan. Bull Tokai Reg Fish Lab 43:89-94.
5. Baran AA. (1988). Flocculation of cellular suspensions by polyelectrolytes. Colloids Surf A 31:259-264.
6. Bu J, Song Y, Rompatoa G, Burgess DJ, Garmendia AE. (2003). Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180. Comp Immunol Microbiol Infect Dis 26:175-187.
7. Deng QY, Zhou CR, Luo BH. (2006). Preparation and characterization of chitosan nanoparticles containing lysozyme. Pharm Biol 44:336-342.
8. Diebold Y, Jarrin M, Saez V, Carvalho ELS, Orea M, Calonge M, et al. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28:1553-1564.
9. Gan Q, Wang T. (2007). Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Coll Surf B 59:24-34.
10. Gregoriadis G, Saffie R, de Souza JB. (1997). Liposome-mediated DNA vaccination. FEBS Lett 402:107-110.
11. Guo J, Ping Q, Jiang G, Huang L, Tong Y. (2003). Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm 260:167-173.
12. Guzey D, McClements DJ. (2006). Formation, stability, and properties of multilayer emulsions for application in the food industry. Adv Coll Interf Sci 130:227-248.
13. Haidar Z, Hamdy RC, Tabrizian M. (2008). Protein release kinetics for core-shell hybrid nanoparticles besed on the layer-by-layer assembly of alginate and chitosan liposomes. Biomaterials 29:1207-1215.
14. Henriksen I, Smistad G, Karlsen J. (1994). Interactions between liposomes and chitosan. Intl J Pharm 101:227-236.
15. Hong YH, McClements DJ. (2007). Modulation of pH sensitivity of surface charge and aggregation stability of protein-coated lipid droplets by chitosan addition. Food Biophys 2:46-55.
16. Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326-1331.
17. Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. (2001). Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51:81-96.
18. Iwanaga K, Ono S, Narioka K, Kakemi M, Morimoto K, Yamashita S, et al. (1999). Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J Pharm Sci 88:248-255.
19. Janes KA, Calvo P, Alonso MJ. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47:83-92.
20. Kato Y, Hosokawa T, Hayakawa E, Ito K. (1993). Influence of liposomes on tryptic digestion of insulin. Biol Pharm Bull 16:457-461. (Pubitemid 23208662)
21. Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. (2008). Surface-modified liposomes for nasal delivery of DNA vaccine. Vaccine 26:2225-2233.
22. Kurita K, Kaji Y, Mori T, Nishiyama Y. (2000). Enzymatic degradation of β-chitin: susceptibility and the influence of deacetylation. Carbohydr Polym 42:19-21.
23. Laye C, McClements DJ, Weiss J. (2008). Formation of biopolymercoated liposomes by electrostatic deposition of chitosan. J Food Sci 73:N7-N15.
24. Lowry O, Rosebrough N, Farr A, Randall R. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
25. Madrigal-Carballo S, Rodriguez G, Sibaja M, Reed JD, Vila AO, Molina F. (2009). Chitosomes loaded with cranberry proanthocyanidins attenuate the bacterial lipopolysaccharide induced expression of iNOS and COX-2 in raw 264.7 macrophages. J Liposome Res doi:10.1080/08982100902729436. (in press)
26. Madrigal-Carballo S, Seyler D, Manconi M, Mura S, Vila AO, Molina F. (2008). An approach to rheological and electrokinetic behaviour of lipidic vesicles covered with chitosan biopolymer. Coll Surf A 323:149-154.
27. Manconi M, Aparicio J, Seyler D, Vila AO, Figueruelo J, Molina F. (2005). Effect of several electrolytes on the rheopectic behaviour of concentrated soy lecithin dispersions. Coll Surf A. 270-271:102-106.
28. McNeela EA, Jabbal-Gill I, Illum L, Pizza M, Rappuoli R, Podda A. (2004). Intranasal immunization with genetically detoxified diphtheria toxin induces T-cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 22:909-914.
29. Mills KH, Cosgrove C, McNeela EA, Sexton A, Giemza R, Jabbal-Gill I, et al. (2003). Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral primingboosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A. Infect Immun 71:726-732.
30. Mishra D, Mishra PK, Dubey V, Dabadghao S, Jain NK. (2007). Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigenloaded elastic liposomes. Vaccine 25:6939-6944.
31. Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, et al. (1999). Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Contr Rel 61:233-240.
32. Nelson DS. (1977). Macrophages and Immunity. Int J Clin Lab Res. 7:93-101.
33. Nishimura K, Ishihara C, Ukei S, Tokura S, Azuma I. (1986). Stimulation of cytokine production in mice using deacetylated chitin. Vaccine 4:151-156.
34. Nishimura K, Nishimura S, Nishi N, Saiki I, Tokura S, Azuma I. (1984). Immunological activity of chitin and its derivatives. Vaccine 2:93-99.
35. Olsen R, Schwartzniller D, Weppner W, Winandy R. (1989). Biomedical applications of chitin and its derivatives. In: Skjak-Braek G, Antonsen T, Sandorf P (Eds), Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties, and Applications (pp 813-828). London: Elsevier.
36. Onishi H, Machida Y. (1992). Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175-182.
37. Pallandre S, Decker EA, McClements DJ. (2007). Improvement of stability of oil-in-water emulsions containing caseinatecoated droplets by addition of sodium alginate. J Food Sci 72:E518-E524.
38. Peek LJ, Middaugh CR, Berkland C. (2008). Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915-928.
39. Ravi Kumar MNV, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. (2004). Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017-6084.
40. Read RC, Naylor SC, Potter CW, Bond J, Jabbal-Gill I, Fisher A. (2005). Effective nasal influenza vaccine delivery using chitosan. Vaccine 23:4367-4374.
41. Saupe A, McBurney W, Rades T, Hook S. (2006). Immunostimulatory colloidal delivery systems for cancer vaccines. Exp Opin Drug Deliv 3:345-354.
42. Seferian PG, Martinez ML. (2001). Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 19:661-668.
43. Sessa G, Weissmann G. (1970). Incorporation of lysozyme into liposomes: a model for structure-linked latency. J Biol Chem 245:3295-3301.
44. Singla AK, Chawla M. (2001). Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 53:1047-1067.
45. Stagg AJ, Hart AL, Knight SC, Kamm MA. (2003). The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52:1522-1529.
46. Sumamoto J, Iwamoto K, Kondo H, Shinkai S. (1980). Liposomal membranes: VI. Polysaccharide induced aggregation of multilamellar liposomes of egg lecithin. J Biochem 88:1219-1226.
47. Sumamoto J, Iwamoto K, Takada M, Yuzuriha T, Katayama K. (1984). Improved drug delivery to target specific organs using liposomes as coated with polysaccharides. In: Chiellini E, Giusti P (Eds.), Polymers in Medicine (pp 157-168). New York: Plenum.
48. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan- coated liposomes. Pharm Res 13:896-901.
49. Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y. (2006). Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J Liposome Res 16:127-141.
50. Van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. (2001). Chitosan for mucosal vaccination. Adv Drug Deliv Rev 52:139-144.
51. Van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE. (2001). Chitosan microparticles for oral vaccination: preparation, characterization, and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22:687-694. (Pubitemid 32112293)
52. Varum KM, Holme HK, Izume M, Stokke BT, Smidsrod O. (1996). Determination of enzymatic hydrolysis specificity of partially N-acetylated chitosans. Biochem Biophys Acta 1291:5-15.
53. Werlra M, Takeuchi H. (2009). Chitosan-aprotinin-coated liposomes for oral peptide delivery: development, characterization, and in vivo evaluation. Int J Pharm 370:26-32.
54. Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Shimokawa M. (2004). Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine. Biochem Biophys Res Commun 325:500-505.
55. Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. (2007). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25:2085-2094.
56. Zaura M, Manca ML, Fadda AM, Antimisiaris SG. (2009). Chitosancoated liposomes for delivery to lungs by nebulisation. Coll Surf B. 71:88-95.doi:10.1016/j.colsurfb.2009.01.010.